Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Netscientific Plc LSE:NSCI London Ordinary Share GB00BN4R5Q82 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -10.00 -7.35% 126.00 124.00 130.00 137.00 120.50 137.00 950,428 16:35:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 0.4 -2.4 -2.9 - 19

Netscientific Share Discussion Threads

Showing 3476 to 3500 of 3500 messages
Chat Pages: 140  139  138  137  136  135  134  133  132  131  130  129  Older
DateSubjectAuthorDiscuss
12/6/2021
22:28
Interesting. Didn't realise this. The Management of Glycotest (ostensibly a US Company) is mainly the UK NSCI guys and also the ProAxsis main guys. Given what ProAxsis are achieving with getting deals done with AstraZeneca that is very impressive. Prof Stephen Smith in particular has very impressive background at nexus of NHS/Academia/Business will open doors for Glycotest in UK NHS circles but give serious imprimatur of quality worldwide
the stigologist
11/6/2021
17:08
JJ, long time bud... Hope all is well, did you buy any NSCI
samsung2020
11/6/2021
16:32
MASSIVE MUG PUNTER!! CHESTY18 Jun '21 - 14:46 - 3288 of 3469 0 1 0 Attacking back thru £2 again!
jibba jabber
11/6/2021
16:22
Alot of buys showing up as sells. All my buys today have shown as red....
samsung2020
11/6/2021
16:10
Nextlink.....don't be rude now...unfilter me......I need to trade!!!! :P
k1ngkonggb
11/6/2021
16:08
It was overbought and now its finding its natural level.
saint in exile
11/6/2021
16:06
It would not surprise me if letmepass also posts as 36jay along with a string of other accounts he has form, posts as shirley83 too
dave4545
11/6/2021
16:00
IG was on 122p when the offer was 121p
demark
11/6/2021
15:55
Looks like some bad news on the way
letmepass
11/6/2021
15:37
124.8p offer now Getting tempted but also getting greedy see if I can get slightly lower
dave4545
11/6/2021
15:32
k1ngkonggb - 11 Jun 2021 - 15:19:55 - 3460 of 3462 NetScientific PLC - NSCI £1 COMING k1ngkonggb - 09 Jun 2021 - 16:30:06 - 3386 of 3462 NetScientific PLC - NSCI Great top up time :) k1ngkonggb - 09 Jun 2021 - 13:44:06 - 3374 of 3462 NetScientific PLC - NSCI 140-150 is the range but it won't stay long at this....much higher to come. k1ngkonggb - 09 Jun 2021 - 11:36:41 - 3367 of 3462 NetScientific PLC - NSCI This might come down to 140-150 range and not too long before it pumps over £2. As Stig points out, the jewel is the Glycotest connection. I can forsee this hitting £10 within a year if all comes to fruition. k1ngkonggb11 Jun '21 - 15:19 - 3460 of 3461 (Filtered)
nextlink
11/6/2021
15:26
That's the thing with placings, if they managed to forward sell quite a few at 150-200p for 1-2 days then sell a load more at 132-145p after announcing it they will not mind taking a small hit selling the rest hence the price has gone slightly below.
dave4545
11/6/2021
15:19
£1 COMING
k1ngkonggb
11/6/2021
13:38
NSCI will come good once the shares have been churned!
chesty1
11/6/2021
13:37
CHESTY111 Jun '21 - 10:24 - 3456 of 3457 Edit 0 1 0 SAR on the move big time folks....News due anytime now! From now on I am not giving away free tips haha! It's flying!
chesty1
11/6/2021
11:48
I would suggest the value of ProAxsis has gone up more than 30% following that deal with AZ. If NSCI only owned that unit, the market would value it on future potential. At present the market is playing the discount to NAV game - but is that appropriate when they own nearly 100% of a company? Look at ODX for example. NSCI now has funds to bring the CV test to full commercialisation.
weatherman
11/6/2021
10:24
SAR on the move big time folks....News due anytime now!
chesty1
11/6/2021
10:14
Market tends to always take it below placing price!
chesty1
11/6/2021
09:52
They increased the unrisked value of ProAxsis, Glycotest, PDS by approx 30% each, cut the WACC for ProAxsis & Glycotest from 20% to 15% so risked values all up approx +40%.
bertiebingo
11/6/2021
08:59
revised broker note this am: WHI View: The success of the placing further illustrates the momentum NSCI is seeing under a rejuvenated strategy and strengthened management team. Our updated risked-based SOTP analysis implies fair value of 162p per share (assuming a revised 21m shares in issue), the recapitalised and strengthened balance sheet reducing the risk profile of the Group and the PDS holding (NASDAQ:PDSB) increasing in value by 36% since our re-initiation on 25 May. A number of potential catalysts exist that could yield significant value inflection points for NSCI. NSCI’s unrisked holding in PDS Biotech2 (5.75%) alone has a realisable value of £10.4m, 37% of the NSCI’s market capitalisation (based on the enlarged share capital).
kalkaar
11/6/2021
08:52
The trades at 131p are buys
blakieboy7
11/6/2021
08:50
At this valuation, and with the recent newsflow, the appetite from serious investors will easily soak up selling from any remaining traders. Huge Placing interest @ 130p will put a solid floor on the SP
mavern
11/6/2021
08:32
Yeah it looks weak. I wonder if it can hold the placing price. Victim of it's own success being top riser 2 days running meaning saturated with traders and no matter how good the news they all move on regardless.
dave4545
11/6/2021
08:28
Managed to buy More at 131p
blakieboy7
10/6/2021
23:07
The AstraZeneca thing came out of left-field Because NSCI are involved in 'game changing US technologies' and looking to be an active catalyst not just a passive investor there is scope for much more newsflow going forward now NSCI is properly funded and have activist 'proven' Management in charge I think we could see a hyper growth phase as the Market realises this is almost a IP Group Mk II which I believe trades at a premium to its NAV at c.£1.26bn
the stigologist
Chat Pages: 140  139  138  137  136  135  134  133  132  131  130  129  Older
ADVFN Advertorial
Your Recent History
LSE
NSCI
Netscienti..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210613 05:26:32